[Effect of corticotropin on endocrine gland functions in endocrine diseases]. 1979

V N Slavnov, and E V Epshteĭn, and V D Malinkovich, and E V Luchitskiĭ, and A A Iakovlev

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003480 Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. Cushing's Syndrome,Hypercortisolism,Syndrome, Cushing,Syndrome, Cushing's
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004700 Endocrine System Diseases Pathological processes of the ENDOCRINE GLANDS, and diseases resulting from abnormal level of available HORMONES. Endocrine Diseases,Diseases of Endocrine System,Disease, Endocrine,Disease, Endocrine System,Diseases, Endocrine,Diseases, Endocrine System,Endocrine Disease,Endocrine System Disease,System Disease, Endocrine,System Diseases, Endocrine
D004702 Endocrine Glands Ductless glands that secrete HORMONES directly into the BLOOD CIRCULATION. These hormones influence the METABOLISM and other functions of cells in the body. Endocrine Gland,Gland, Endocrine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol

Related Publications

V N Slavnov, and E V Epshteĭn, and V D Malinkovich, and E V Luchitskiĭ, and A A Iakovlev
June 1971, L'union medicale du Canada,
V N Slavnov, and E V Epshteĭn, and V D Malinkovich, and E V Luchitskiĭ, and A A Iakovlev
January 1953, Revista de la Sociedad Argentina de Biologia,
V N Slavnov, and E V Epshteĭn, and V D Malinkovich, and E V Luchitskiĭ, and A A Iakovlev
May 1974, Horumon to rinsho. Clinical endocrinology,
V N Slavnov, and E V Epshteĭn, and V D Malinkovich, and E V Luchitskiĭ, and A A Iakovlev
June 1999, Presse medicale (Paris, France : 1983),
V N Slavnov, and E V Epshteĭn, and V D Malinkovich, and E V Luchitskiĭ, and A A Iakovlev
November 1988, Medizinische Klinik (Munich, Germany : 1983),
V N Slavnov, and E V Epshteĭn, and V D Malinkovich, and E V Luchitskiĭ, and A A Iakovlev
January 1989, Doklady Akademii nauk SSSR,
V N Slavnov, and E V Epshteĭn, and V D Malinkovich, and E V Luchitskiĭ, and A A Iakovlev
February 1961, France Medecine,
V N Slavnov, and E V Epshteĭn, and V D Malinkovich, and E V Luchitskiĭ, and A A Iakovlev
January 1948, The Medical clinics of North America,
V N Slavnov, and E V Epshteĭn, and V D Malinkovich, and E V Luchitskiĭ, and A A Iakovlev
March 2005, Journal of UOEH,
V N Slavnov, and E V Epshteĭn, and V D Malinkovich, and E V Luchitskiĭ, and A A Iakovlev
February 2009, Journal of endocrinological investigation,
Copied contents to your clipboard!